The global fibrin sealants market size is anticipated to reach USD 1,156.6 million by 2026, displaying a CAGR of 6.6% during the forecast period. Rising prevalence of cardiovascular diseases (CVDs) worldwide is likely to play a vital role in driving the growth of this market in the coming years. According to estimates released by the World Health Organization (WHO), CVDs have become the number one cause of death globally, responsible for the death of over 17 million people around the world. These diseases are causing high mortality even in developed countries. For instance, the American College of Cardiology states that CVDs killed close to 840,768 Americans in 2016. CVDs are chronic in nature and eventually require invasive surgeries. Fibrin sealants are critical components in surgeries, especially those of the heart, as they are the most effective and efficient tissue adhesives available in the market. Thus, as the incidence of heart surgeries rises, the demand for fibrin glues will grow, as per the fibrin sealants market analysis.
Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/fibrin-sealants-market-100316
The new Fortune Business Insights™ report, titled “Fibrin Sealants Market Size, Share & Industry Analysis, By Type (Liquid, and Patches) By Application (Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery, and Others) By End User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2019-2026”, states that the value of the market stood at USD 701.4 million in 2018. The report further shares the following information:
- Comprehensive analysis of the upcoming trends and prospects in the market;
- 360-degree evaluation of the factors driving and restraining market growth;
- Detailed research into the regional and competitive landscape influencing the market; and
- Careful study of the market segments.
Growing Usage of Hemostats in Operative Procedures to Feed Market Growth
One of the top fibrin sealants market trends is the high demand and utilization of hemostats for surgeries. Hemostats, or clamps, are devices used in surgical procedures to control bleeding. They are widely employed in complex procedures, such as during cardiac surgeries, where utmost care needs to be taken. The demand for these devices is further bolstered by the fact that the number of heart surgeries in the world is escalating. A survey conducted by the American Hospital Association found that in 2014 approximately 17.2 million patients had to undergo invasive cardiac surgery in the US. Furthermore, increasing demand for these materials has prompted market players to innovate and launch new products. For example, Baxter unveiled its new Tisseel Prima Syringe, an ergonomic device that is fully assembled and much more convenient to use than its older variant, in November 2018.
Quick Buy:
https://www.fortunebusinessinsights.com/checkout-page/100316
Introduction of Innovation Solutions to Spur Competition
Key players market are taking several efforts to establish and consolidate their position in this market, the fibrin glue market forecast says. The go-to strategy for companies is frequent launch of new products and collaborating with other competitors in the market.
Industry Developments:
- June 2019: The Spanish pharmaceutical giant, Grifols, announced that it has received 510 (k) approval from the US FDA to market the fibrin glue, Vistaseal, in the US. Grifols developed the sealant and will market it with its partner, Ethicon, under their 10-year collaboration agreement signed in 2017.
- December 2019: New Jersey-based Johnson & Johnson’s subsidiary, Ethicon, launched its fibrin sealant, Vistaseal, for controlling bleeding during surgeries. The offering is unique because it is the first-of-its-kind sealant that is designed to be sprayed without gas for minimally invasive procedures.
Prominent Players Profiled in the Fibrin Sealants Market Report:
- Vivostat A/S
- Johnson & Johnson Services, Inc.
- CSL Limited
- Stryker
- Takeda Pharmaceutical Company Limited
- Baxter
Speak to Analyst at
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/fibrin-sealants-market-100316
Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Technological Advancements in Fibrin Sealants Market
- New Product Launches by Key Players
- Key Industry Developments: Mergers, Acquisitions & Partnerships
- Overview of Regulatory Scenario - Key Countries
- Prevalence of Major Surgical Procedures for Key Countries
- Trends of Usage of Fibrin Sealants
ToC Continue…
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:[email protected]
The global fibrin sealants market size is anticipated to reach USD 1,156.6 million by 2026, displaying a CAGR of 6.6% during the forecast period.
Rising prevalence of cardiovascular diseases (CVDs) worldwide is likely to play a vital role in driving the growth of this market in the coming years.
These diseases are causing high mortality even in developed countries.
For instance, the American College of Cardiology states that CVDs killed close to 840,768 Americans in 2016.
Fibrin sealants are critical components in surgeries, especially those of the heart, as they are the most effective and efficient tissue adhesives available in the market.
Thus, as the incidence of heart surgeries rises, the demand for fibrin glues will grow, as per the fibrin sealants market analysis.For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/fibrin-sealants-market-100316Prominent Players Profiled in the Fibrin Sealants Market Report:Vivostat A/SJohnson & Johnson Services, Inc.CSL LimitedStrykerTakeda Pharmaceutical Company LimitedBaxterRequest a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/fibrin-sealants-market-100316The new Fortune Business Insights™ report, titled “Fibrin Sealants Market Size, Share & Industry Analysis, By Type (Liquid, and Patches) By Application (Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery, and Others) By End User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2019-2026”, states that the value of the market stood at USD 701.4 million in 2018.
Market Overview-The global fibrin sealant patch market size is expected to gain momentum owing to the growing number of surgeries worldwide during the forecast period.
This information is published by Fortune Business Insights™ in an upcoming report, titled, “Fibrin Sealant Patch Market, 2021-2028.” The development of the market is being fueled by the increasing number of surgical procedures, particularly orthopedic surgeries due to sports injuries, accidents, and cardiac surgeries.
According to World Health Organization (WHO) estimates, cardiovascular diseases surpassed cancer as the leading cause of death worldwide, killing approximately 17 million people.Request a Sample Copy of the Research ReportCOVID-19 Impact-Supply Chain Disruption to Hamper the Market GrowthCOVID-19 is an unprecedented global public health crisis that has impacted practically every business, with long-term consequences that are expected to stifle industrial growth during the forecast period.
By end-user, the market is segregated into hospitals, specialty clinics, ambulatory surgery centers, and others.
Hemostats, often known as clamps, are devices that are used to stop bleeding during surgical procedures.
The rapid expansion of the global fibrin sealants market is due to advancements in healthcare infrastructure, an increase in the number of bone and sports injuries, and the growing number of hip and knee replacement procedures in the United States.Europe is anticipated to hold a substantial position in the market.
Disposable hemostatic agents are emerging technology in the field of hemostatic agents.
In improving hemostasis, disposable hemostatic agents play a prominent role by enhancing fibrin formation.
Disposable hemostatic agents have applications in the urological treatment field.
The factors projected to drive the global disposable hemostatic agents market are the rising incidence of hemorrhage in surgery and the increasing importance of blood management.
In addition, the innovations in surgical procedures such as robot-assisted surgery and the increasing elderly population are anticipated to fuel the demand for global disposable hemostatic agents.
The Disposable Hemostatic Agents Market is estimated to grow at the rate of 5.3% CAGR by 2026.
